首页 > 市场调查报告书 > 製药

眼科药物

2030 年亚太地区眼药水市场预测 - 区域分析 - 按类型（抗生素、人工泪液、荷尔蒙等）、应用和购买模式（非处方药和处方药）

市场调查报告书

商品编码

1402534

2030 年亚太地区眼药水市场预测 - 区域分析 - 按类型（抗生素、人工泪液、荷尔蒙等）、应用和购买模式（非处方药和处方药）

Asia Pacific Eye Drops Market Forecast to 2030 - Regional Analysis - by Type (Antibiotics, Artificial Tears, Hormones, and Others), Application, and Purchase Mode (OTC and Prescription)

出版日期: 2023年11月07日 | 出版商:

The Insight Partners | 英文 96 Pages | 订单完成后即时交付

价格

简介目录图表

亚太地区滴眼剂市场预计将从2022年的28.2384亿美元成长到2030年的43.8659亿美元。预计2022年至2030年CAGR为5.7%。

不断涌现的眼部护理措施推动亚太眼药水市场

近年来，人们采取了各种措施和努力来提高人们对眼部疾病的认识和教育，促使患者获得合适的药物和治疗。

Sightsavers 是一个国际非政府组织，致力于在发展中国家治疗和预防眼部疾病。印度大量人口居住在农村地区，对眼病的认识有限或根本没有。 Sightsavers 旨在透过其农村眼健康计划提高人们的意识，提供高品质的眼部健康服务，并消除农村人口中可避免的失明。此外，世卫组织于2019年启动了全民健康覆盖和眼保健：促进国家行动，旨在提供实用的分步指导，支持世卫组织会员国规划和实施世卫组织世界报告的建议关于视力。世界卫生组织发起此活动的目的是提供以人为本的综合眼科保健服务。此外，2020 年印美合作视觉研究计画的重点是推进对于理解、预防和治疗致盲眼症、视力障碍及相关併发症至关重要的科学和技术。印度生物技术部和美国 NEI 资助了该研究计画。

2021 年 12 月，NIH 资助的计画支持凯洛格眼科中心和阿拉文眼科医院（印度）之间的合作伙伴关係，为眼保健专家开发临床研究培训计画。此类培训计划旨在发展印度的眼保健领域。因此，增加眼保健研究资金可能为眼药水市场参与者提供成长机会。

亚太地区眼药水市场概况

亚太地区滴眼剂市场细分为中国、日本、印度、澳洲、韩国和亚太地区其他地区。预计亚太地区在预测期内复合CAGR最快。亚太地区市场的成长归因于澳洲和印度等国家干眼症的日益普及。此外，老年人口的成长、医疗保健基础设施的发展以及为促进研究活动而增加的投资预计将在预测期内推动亚太地区滴眼剂市场的发展。在中国，每年约有20-30%的人被诊断出有干眼症。导致干眼症的主要因素包括长时间坐在电脑、笔记型电脑和手机前。此外，高空气污染程度是该国干眼症的另一个主要原因。该国是亚太地区糖尿病和青光眼发病率最高的国家，这可能会导致干眼症。中国也是原料药生产和仿製药的最大市场。该国多家公司参与眼科产品的生产。 2023年4月，Ocumension Therapeutics提交新药申请（NDA），批准Zerviate 0.24%（西替利嗪）滴眼液在中国商业化。此溶液主要用于减少与过敏性结膜炎相关的眼部搔痒。

中国的亚太滴眼剂市场竞争相当激烈，国内外药厂都有驻足。该国的一些知名国产眼药水品牌包括参天、诺华、爱尔康、艾尔建和博士伦，它们提供一系列眼部护理产品，包括处方眼药水和非处方眼药水 (OTC)解决方案。中国眼药水的通路包括医院、诊所、药局和电商平台。医院和诊所通常是提供处方眼药水的公司首选的经销商，而非处方眼药水则可以在药房和线上平台上轻鬆买到。

亚太地区眼药水市场收入及 2030 年预测（百万美元）

亚太地区眼药水市场区隔

亚太地区滴眼剂市场按类型、应用、购买模式和国家细分。

根据类型，亚太地区眼药水市场分为抗生素、人工泪液、荷尔蒙等。 2022年，抗生素细分市场在亚太地区眼药水市场中占据最大份额。

根据应用，亚太地区眼药水市场分为眼疾、眼部保健等。 2022年，眼疾细分市场在亚太眼药水市场中占据最大份额。眼疾细分市场进一步细分为干眼症、青光眼、白内障等。

根据购买模式，亚太地区眼药水市场分为非处方药和处方药。 2022 年，处方药细分市场在亚太地区眼药水市场中占有更大份额。

依国家划分，亚太地区眼药水市场分为中国、日本、印度、澳洲、韩国和亚太地区其他地区。 2022年，中国主导亚太地区眼药水市场。

艾伯维公司、爱尔康公司、博士伦公司、Biomedica Pvt Ltd、辉瑞公司、Prestige Consumer Healthcare Inc.和乐敦製药有限公司是亚太滴眼剂市场上的一些领先公司。

Sightsavers-an international nongovernmental organization-works in developing countries to treat and prevent eye diseases. A large population in India resides in rural areas with limited or no awareness of eye ailments. Sightsavers aims to create awareness with its Rural Eye Health Programme, provide high-quality eye health services, and eradicate avoidable blindness in the rural population. In addition, in 2019, the WHO launched the Universal Health Coverage and Eye Care: Promoting Country Action, an event to provide practical, step-by-step guidance to support Member States of WHO in planning and implementing the recommendations of the WHO's World Report on vision. The WHO launched this event to provide integrated people-centered eye care services. Further, the India-US Collaborative Vision Research Program 2020 focuses on advancing science and technology crucial to understand, prevent, and treat blinding eye diseases, visual disorders, and associated complications. The Indian Department of Biotechnology and the US NEI fund this research program.

In December 2021, NIH-funded projects supported the partnership between Kellogg Eye Center and Aravind Eye Hospital (India) to develop a clinical research training program for eyecare specialists. Such training programs are meant to develop the eyecare field in India. Thus, increasing funds for eyecare research will likely offer growth opportunities to the eye drop market players.

Asia Pacific Eye Drops Market Overview

The Asia Pacific eye drops market is sub segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. Asia Pacific is expected to register the fastest CAGR during the forecast period. The growth of the market in Asia Pacific is attributed to the growing prevalence of dry eye diseases in countries such as Australia, and India. Additionally, the growing geriatric population, developing healthcare infrastructure, and increasing investments to boost research activities are projected to drive the Asia Pacific eye drops market during the forecast period. In China, every year about 20-30% of people are diagnosed with dry eye conditions. Major factors causing dry eye condition include long spending hours in front of computers, laptops, and mobile phones. Moreover, high air pollution level is another leading cause of dry eye condition in the country. The country records the highest incidences of diabetes and glaucoma in Asia Pacific, which may lead to a dry eye condition. China is also the largest market for API manufacturing and generic pharmaceuticals. Various companies in the country are involved in the production of ophthalmic products. In April 2023, Ocumension Therapeutics submitted a new drug application (NDA) for approval to commercialize Zerviate 0.24% (cetirizine) ophthalmic solution in China. This solution is majorly used to reduce ocular itching associated with allergic conjunctivitis.

The Asia Pacific eye drops market in China is quite competitive, with the presence of both domestic and international pharmaceutical companies. A few of the well-known domestic eye drop brands in the country are Santen, Novartis, Alcon, Allergan, and Baush + Lomb, which offer a range of eye care products, including prescription-based eye drops and over the counter (OTC) solutions. The distribution channels for eye drops in China include hospitals, clinics, pharmacies, and e-commerce platforms. Hospitals and clinics are commonly preferred as distributors by companies offering prescription-based eye drops, while OTC eye drops are readily available in pharmacies and online platforms.

Asia Pacific Eye Drops Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Eye Drops Market Segmentation

The Asia Pacific eye drops market is segmented into type, application, purchase mode, and country.

Based on type, the Asia Pacific eye drops market is segmented into antibiotics, artificial tears, hormones, and others. The antibiotics segment held the largest share of the Asia Pacific eye drops market in 2022.

Based on application, the Asia Pacific eye drops market is segmented into eye diseases, eye care, and others. The eye diseases segment held the largest share of the Asia Pacific eye drops market in 2022. The eye diseases segment is further segmented into dry eye, glaucoma, cataract, and others.

Based on purchase mode, the Asia Pacific eye drops market is segmented into OTC and prescription. The prescription segment held a larger share of the Asia Pacific eye drops market in 2022.

Based on country, the Asia Pacific eye drops market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific eye drops market in 2022.

AbbVie Inc, Alcon AG, Bausch & Lomb Inc, Biomedica Pvt Ltd, Pfizer Inc, Prestige Consumer Healthcare Inc., and Rohto Pharmaceutical Co Ltd are some of the leading companies operating in the Asia Pacific eye drops market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific Eye Drops Market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific Eye Drops Market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Asia Pacific Eye Drops Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 Asia Pacific PEST Analysis
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
4.4 Pipeline Analysis

5. Asia Pacific Eye Drops Market - Key Industry Dynamics

5.1 Market Drivers
- 5.1.1 Rising Prevalence of Ophthalmic Diseases
- 5.1.2 High Incidence of Age-Related Eye Diseases
5.2 Market Restraints
- 5.2.1 Product Recalls
5.3 Market Opportunities
- 5.3.1 Rising Initiatives for Eye Care
5.4 Future Trends
- 5.4.1 Changing Lifestyle
5.5 Impact Analysis

6. Eye Drops Market - Asia Pacific Market Analysis

6.1 Asia Pacific Eye Drops Market Revenue (US$ Mn), 2022 - 2030

7. Asia Pacific Eye Drops Market - Revenue and Forecast to 2030 - by Type

7.1 Overview
7.2 Asia Pacific Eye Drops Market Revenue Share, by Type 2022 & 2030 (%)
7.3 Antibiotics
- 7.3.1 Overview
- 7.3.2 Antibiotics: Asia Pacific Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Artificial Tears
- 7.4.1 Overview
- 7.4.2 Artificial Tears: Asia Pacific Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Hormones
- 7.5.1 Overview
- 7.5.2 Hormones: Asia Pacific Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Others
- 7.6.1 Overview
- 7.6.2 Others: Asia Pacific Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Eye Drops Market - Revenue and Forecast to 2030 - by Application

8.1 Overview
8.2 Asia Pacific Eye Drops Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Eye Diseases
- 8.3.1 Overview
- 8.3.2 Eye Diseases: Asia Pacific Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.1 Dry Eye
    - 8.3.2.1.1 Overview
  - 8.3.2.2 Dry Eye: Asia Pacific Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.3 Glaucoma
    - 8.3.2.3.1 Overview
    - 8.3.2.3.2 Glaucoma: Asia Pacific Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.4 Cataract
    - 8.3.2.4.1 Overview
    - 8.3.2.4.2 Cataract: Asia Pacific Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.5 Others
    - 8.3.2.5.1 Overview
    - 8.3.2.5.2 Others: Asia Pacific Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Eye Care
- 8.4.1 Overview
- 8.4.2 Eye Care: Asia Pacific Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Others
- 8.5.1 Overview
- 8.5.2 Others: Asia Pacific Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Eye Drops Market - Revenue and Forecast to 2030 - by Purchase Mode

9.1 Overview
9.2 Asia Pacific Eye Drops Market Revenue Share, by Purchase Mode 2022 & 2030 (%)
9.3 Prescription
- 9.3.1 Overview
- 9.3.2 Prescription: Asia Pacific Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
9.4 OTC
- 9.4.1 Overview
- 9.4.2 OTC: Asia Pacific Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Eye Drops Market - Revenue and Forecast to 2030 - Country Analysis

10.1 Asia Pacific Eye Drops Market
- 10.1.1 Overview
- 10.1.2 Asia Pacific Eye Drops Market, by Country, 2022 & 2030 (%)
  - 10.1.2.1 China: Asia Pacific Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.1.1 Overview
    - 10.1.2.1.2 China: Asia Pacific Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.1.3 China: Asia Pacific Eye Drops Market, by Drug Class, 2020-2030 (US$ Million)
    - 10.1.2.1.4 China: Asia Pacific Eye Drops Market, by Application, 2020-2030 (US$ Million)
    - 10.1.2.1.4.1 China: Asia Pacific Eye Drops Market, by Eye Disease, 2020-2030 (US$ Million)
    - 10.1.2.1.5 China: Asia Pacific Eye Drops Market, by Purchase Mode, 2020-2030 (US$ Million)
  - 10.1.2.2 Japan: Asia Pacific Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.2.1 Overview
    - 10.1.2.2.2 Japan: Asia Pacific Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.2.3 Japan: Asia Pacific Eye Drops Market, by Type, 2020-2030 (US$ Million)
    - 10.1.2.2.4 Japan: Asia Pacific Eye Drops Market, by Application, 2020-2030 (US$ Million)
    - 10.1.2.2.4.1 Japan: Asia Pacific Eye Drops Market, by Eye Diseases, 2020-2030 (US$ Million)
    - 10.1.2.2.5 Japan: Asia Pacific Eye Drops Market, by Purchase Mode, 2020-2030 (US$ Million)
  - 10.1.2.3 India: Asia Pacific Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.3.1 Overview
    - 10.1.2.3.2 India: Asia Pacific Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.3.3 India: Asia Pacific Eye Drops Market, by Type, 2020-2030 (US$ Million)
    - 10.1.2.3.4 India: Asia Pacific Eye Drops Market, by Application, 2020-2030 (US$ Million)
    - 10.1.2.3.4.1 India: Asia Pacific Eye Drops Market, by Eye Diseases, 2020-2030 (US$ Million)
    - 10.1.2.3.5 India: Asia Pacific Eye Drops Market, by Purchase Mode, 2020-2030 (US$ Million)
  - 10.1.2.4 Australia: Asia Pacific Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.4.1 Overview
    - 10.1.2.4.2 Australia: Asia Pacific Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.4.3 Australia: Asia Pacific Eye Drops Market, by Type, 2020-2030 (US$ Million)
    - 10.1.2.4.4 Australia: Asia Pacific Eye Drops Market, by Application, 2020-2030 (US$ Million)
    - 10.1.2.4.4.1 Australia: Asia Pacific Eye Drops Market, by Eye Diseases, 2020-2030 (US$ Million)
    - 10.1.2.4.5 Australia: Asia Pacific Eye Drops Market, by Purchase Mode, 2020-2030 (US$ Million)
  - 10.1.2.5 South Korea: Asia Pacific Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.5.1 Overview
    - 10.1.2.5.2 South Korea: Asia Pacific Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.5.3 South Korea: Asia Pacific Eye Drops Market, by Type, 2020-2030 (US$ Million)
    - 10.1.2.5.4 South Korea: Asia Pacific Eye Drops Market, by Application, 2020-2030 (US$ Million)
    - 10.1.2.5.4.1 South Korea: Asia Pacific Eye Drops Market, by Eye Diseases, 2020-2030 (US$ Million)
    - 10.1.2.5.5 South Korea: Asia Pacific Eye Drops Market, by Purchase Mode, 2020-2030 (US$ Million)
  - 10.1.2.6 Rest of Asia Pacific: Asia Pacific Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.6.1 Overview
    - 10.1.2.6.2 Rest of Asia Pacific: Asia Pacific Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.6.3 Rest of Asia Pacific: Asia Pacific Eye Drops Market, by Type, 2020-2030 (US$ Million)
    - 10.1.2.6.4 Rest of Asia Pacific: Asia Pacific Eye Drops Market, by Application, 2020-2030 (US$ Million)
    - 10.1.2.6.4.1 Rest of Asia Pacific: Asia Pacific Eye Drops Market, by Eye Diseases, 2020-2030 (US$ Million)
    - 10.1.2.6.5 Rest of Asia Pacific: Asia Pacific Eye Drops Market, by Purchase Mode, 2020-2030 (US$ Million)

11. Asia Pacific Eye Drops Market-Industry Landscape

11.1 Overview
11.2 Growth Strategies in the Eye Drops Market (%)
11.3 Organic Developments
- 11.3.1 Overview
11.4 Inorganic Developments
- 11.4.1 Overview

12. Company Profiles

12.1 Alcon AG
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Pfizer Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Prestige Consumer Healthcare Inc.
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Rohto Pharmaceutical Co Ltd
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 AbbVie Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Bausch & Lomb Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Biomedica Pvt Ltd
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments

13. Appendix

13.1 About Us
13.2 Glossary of Terms

简介目录图表

List Of Tables

List of Tables

Table 1. Asia Pacific Eye Drops Market Segmentation
Table 2. List of Vendors
Table 3. China: Asia Pacific Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 4. China: Asia Pacific Eye Drops Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 5. China: Asia Pacific Eye Drops Market, by Eye Disease - Revenue and Forecast to 2030 (US$ Million)
Table 6. China: Asia Pacific Eye Drops Market, by Purchase Mode - Revenue and Forecast to 2030 (US$ Million)
Table 7. Japan: Asia Pacific Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 8. Japan: Asia Pacific Eye Drops Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 9. Japan: Asia Pacific Eye Drops Market, by Eye Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 10. Japan: Asia Pacific Eye Drops Market, by Purchase Mode- Revenue and Forecast to 2030 (US$ Million)
Table 11. India: Asia Pacific Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 12. India: Asia Pacific Eye Drops Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 13. India: Asia Pacific Eye Drops Market, by Eye Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 14. India: Asia Pacific Eye Drops Market, by Purchase Mode - Revenue and Forecast to 2030 (US$ Million)
Table 15. Australia: Asia Pacific Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 16. Australia: Asia Pacific Eye Drops Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 17. Australia: Asia Pacific Eye Drops Market, by Eye Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 18. Australia: Asia Pacific Eye Drops Market, by Purchase Mode - Revenue and Forecast to 2030 (US$ Million)
Table 19. South Korea: Asia Pacific Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 20. South Korea: Asia Pacific Eye Drops Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 21. South Korea: Asia Pacific Eye Drops Market, by Eye Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 22. South Korea: Asia Pacific Eye Drops Market, by Purchase Mode - Revenue and Forecast to 2030 (US$ Million)
Table 23. Rest of Asia Pacific: Asia Pacific Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 24. Rest of Asia Pacific: Asia Pacific Eye Drops Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 25. Rest of Asia Pacific: Asia Pacific Eye Drops Market, by Eye Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 26. Rest of Asia Pacific: Asia Pacific Eye Drops Market, by Purchase Mode- Revenue and Forecast to 2030 (US$ Million)
Table 27. Organic Developments in the Eye Drops Market
Table 28. Inorganic Developments in the Eye drop Market
Table 29. Glossary of Terms, Asia Pacific Eye Drops Market

List Of Figures

List of Figures

Figure 1. Asia Pacific Eye Drops Market Segmentation, By Country
Figure 2. Asia Pacific - PEST Analysis
Figure 3. Pipeline Analysis
Figure 4. Asia Pacific Eye Drops Market: Key Industry Dynamics
Figure 5. Asia Pacific Eye Drops Market: Impact Analysis of Drivers and Restraints
Figure 6. Asia Pacific Eye Drops Market Revenue (US$ Mn), 2020 - 2030
Figure 7. Asia Pacific Eye Drops Market Revenue Share, by Type 2022 & 2030 (%)
Figure 8. Antibiotics: Asia Pacific Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Artificial Tears: Asia Pacific Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Hormones: Asia Pacific Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Others: Asia Pacific Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Asia Pacific Eye Drops Market Revenue Share, by Application 2022 & 2030 (%)
Figure 13. Eye Diseases: Asia Pacific Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Dry Eye: Asia Pacific Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Glaucoma: Asia Pacific Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Cataract: Asia Pacific Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: Asia Pacific Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Eye Care: Asia Pacific Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Others: Asia Pacific Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Asia Pacific Eye Drops Market Revenue Share, by Purchase Mode 2022 & 2030 (%)
Figure 21. Prescription: Asia Pacific Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. OTC: Asia Pacific Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Asia Pacific Eye Drops Market, by Key Country - Revenue (2022) (US$ Million)
Figure 24. Asia Pacific Eye Drops Market, by Country, 2022 & 2030 (%)
Figure 25. China: Asia Pacific Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Japan: Asia Pacific Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. India: Asia Pacific Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Australia: Asia Pacific Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. South Korea: Asia Pacific Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 30. Rest of Asia Pacific: Asia Pacific Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
Figure 31. Growth Strategies in the Eye Drops Market (%)